CNTB
Connect Biopharma Holdings Ltd
0.8807$
-6.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 19 | Q4 19 | Q1 20 | Q2 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +100.0% | -94.9% | -42.7% | -100.0% | – | -66.7% | +0.0% | +956.3% | +1,637.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.1% | – | – | -4.0% | – | – | -1.2% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | – | +68.4% | – | – | – | – | – | – | -3.7% | – | – | -40.1% | -100.0% | +198,708.4% | -79.7% | +68.5% | -30.8% | +6.4% | +32.3% | +26.6% | +1.5% | +33.2% | +8.3% | – | |
| – | +0.0% | – | – | +520.2% | – | – | – | – | – | – | +199,899.9% | – | – | -21.6% | -87.9% | +233,652.7% | -35.6% | +18.2% | -32.6% | +18.0% | -2.4% | +40.1% | -35.5% | +11.8% | -13.6% | – | |
| – | +0.0% | – | – | +897.1% | – | – | – | – | – | – | -5.1% | – | – | -36.1% | -100.0% | +222,262.6% | -71.7% | +43.9% | -31.5% | +11.0% | +17.7% | +31.3% | -12.2% | +27.4% | +103.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -201.5% | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | – | – | – | – | – | – | – | – | -2.6% | – | – | -15.7% | – | – | +92.5% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -186.2% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +84,849,900.0% | -68.9% | +39.7% | -69.1% | -3.3% | – | – | -65.2% | -100.0% | +191,484.0% | -46.4% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -186.7% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.